vs
Resolute Holdings Management, Inc.(RHLD)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
Resolute Holdings Management, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍($117.7M vs $69.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs -1.5%,领先385.5%)
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业,核心业务布局于非洲地区,目前运营两座金矿,分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿,专注于黄金资源的勘探、开采及相关运营管理工作。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
RHLD vs RIGL — 直观对比
营收规模更大
RHLD
是对方的1.7倍
$69.8M
净利率更高
RIGL
高出385.5%
-1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $117.7M | $69.8M |
| 净利润 | $-1.7M | $268.1M |
| 毛利率 | 55.7% | 91.5% |
| 营业利润率 | 30.2% | 33.2% |
| 净利率 | -1.5% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益(稀释后) | $-0.20 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
RHLD
RIGL
| Q4 25 | $117.7M | $69.8M | ||
| Q3 25 | $120.9M | $69.5M | ||
| Q2 25 | $119.6M | $101.7M | ||
| Q1 25 | $103.9M | $53.3M | ||
| Q4 24 | — | $57.6M | ||
| Q3 24 | — | $55.3M | ||
| Q2 24 | — | $36.8M | ||
| Q1 24 | — | $29.5M |
净利润
RHLD
RIGL
| Q4 25 | $-1.7M | $268.1M | ||
| Q3 25 | $-231.0K | $27.9M | ||
| Q2 25 | $-611.0K | $59.6M | ||
| Q1 25 | $-3.4M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | $-1.0M | ||
| Q1 24 | — | $-8.2M |
毛利率
RHLD
RIGL
| Q4 25 | 55.7% | 91.5% | ||
| Q3 25 | 59.0% | 93.2% | ||
| Q2 25 | 57.5% | 95.6% | ||
| Q1 25 | 52.5% | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率
RHLD
RIGL
| Q4 25 | 30.2% | 33.2% | ||
| Q3 25 | 34.3% | 40.9% | ||
| Q2 25 | 34.0% | 60.1% | ||
| Q1 25 | 24.7% | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率
RHLD
RIGL
| Q4 25 | -1.5% | 384.0% | ||
| Q3 25 | -0.2% | 40.2% | ||
| Q2 25 | -0.5% | 58.6% | ||
| Q1 25 | -3.2% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | — | 22.5% | ||
| Q2 24 | — | -2.8% | ||
| Q1 24 | — | -27.9% |
每股收益(稀释后)
RHLD
RIGL
| Q4 25 | $-0.20 | $14.11 | ||
| Q3 25 | $-0.03 | $1.46 | ||
| Q2 25 | $-0.07 | $3.28 | ||
| Q1 25 | $-0.39 | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $205.5M | $155.0M |
| 总债务越低越好 | $169.8M | $52.5M |
| 股东权益账面价值 | $6.5M | $391.5M |
| 总资产 | $333.4M | $513.6M |
| 负债/权益比越低杠杆越低 | 26.03× | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
RHLD
RIGL
| Q4 25 | $205.5M | $155.0M | ||
| Q3 25 | $148.0M | $137.1M | ||
| Q2 25 | $99.9M | $108.4M | ||
| Q1 25 | $71.0M | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务
RHLD
RIGL
| Q4 25 | $169.8M | $52.5M | ||
| Q3 25 | $173.4M | $60.0M | ||
| Q2 25 | $177.1M | $60.0M | ||
| Q1 25 | $180.7M | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益
RHLD
RIGL
| Q4 25 | $6.5M | $391.5M | ||
| Q3 25 | $10.8M | $117.6M | ||
| Q2 25 | $9.6M | $81.9M | ||
| Q1 25 | $8.9M | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-29.9M | ||
| Q1 24 | — | $-31.7M |
总资产
RHLD
RIGL
| Q4 25 | $333.4M | $513.6M | ||
| Q3 25 | $293.2M | $242.5M | ||
| Q2 25 | $253.3M | $206.7M | ||
| Q1 25 | $214.3M | $176.0M | ||
| Q4 24 | — | $164.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | — | $128.4M | ||
| Q1 24 | — | $126.5M |
负债/权益比
RHLD
RIGL
| Q4 25 | 26.03× | 0.13× | ||
| Q3 25 | 16.01× | 0.51× | ||
| Q2 25 | 18.42× | 0.73× | ||
| Q1 25 | 20.38× | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $196.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $189.2M | — |
| 自由现金流率自由现金流/营收 | 160.8% | — |
| 资本支出强度资本支出/营收 | 5.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $313.2M | — |
8季度趋势,按日历期对齐
经营现金流
RHLD
RIGL
| Q4 25 | $196.1M | $22.0M | ||
| Q3 25 | $59.6M | $24.0M | ||
| Q2 25 | $48.9M | $30.5M | ||
| Q1 25 | $18.4M | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | — | $302.0K | ||
| Q1 24 | — | $-5.0M |
自由现金流
RHLD
RIGL
| Q4 25 | $189.2M | — | ||
| Q3 25 | $58.6M | — | ||
| Q2 25 | $47.5M | — | ||
| Q1 25 | $17.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
RHLD
RIGL
| Q4 25 | 160.8% | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 39.7% | — | ||
| Q1 25 | 17.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
RHLD
RIGL
| Q4 25 | 5.8% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率
RHLD
RIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图